<DOC>
	<DOCNO>NCT02020083</DOCNO>
	<brief_summary>The purpose study determine whether transporter expression level drug interaction TDF FTC could contribute modulate placental transfer drug . To test hypothesis , ex vivo model know `` perfused ex vivo cotyledon model '' allow reproduce condition third trimester pregnancy</brief_summary>
	<brief_title>Placental Transfer Tenofovir</brief_title>
	<detailed_description>Nowadays , mother-to-child HIV transmission main cause paediatric HIV infection . Yet , way transmission effectively limit use antiretroviral therapy pregnancy HIV infected woman . The study TEmAA ( ANRS 12109 ) conduct allow u suggest therapeutic scheme administration association tenofovir disoproxil fumarate ( TDF ) - emtricitabine ( FTC ) reduce risk postpartum resistance may occur administration single dose nevirapine delivery . However , also observe large interindividual variability TDF vivo placental transfer remain unexplained . Placental membrane transporter , include efflux transporter belong ABC transporter superfamily uptake transporter , may constitute source variability . In case , show association maraviroc significant inverse correlation clearance index placental expression level several efflux transporter ABCC/MRP family . Regarding TDF , show drug substrate several efflux transporter ( ABCC2/MRP2 , ABCC4/MRP4 , ABCC10/MRP7 ) uptake transporter ( hOAT3 ) . As transporter express placental barrier , may hypothesize expression level could contribute modulate placental transfer drug . To test hypothesis , ex vivo model know `` perfused ex vivo cotyledon model '' allow reproduce condition third trim pregnancy . Our first aim evaluate potential effect ABCC2 , ABCC4 , ABCC10 hOAT3 placental expression TDF placental transfer ( First year ) . We also want investigate whether potential interaction TDF FTC could take part variability .</detailed_description>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Major Patients &gt; = 18 year old At term 37 41 week gestational age Uncomplicated pregnancy Informed Consent Form sign Women HIV+ , HBV+ HBC+ Women cardiovascular disease diabetes preeclampsia , IUGR Women take medication pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter</keyword>
</DOC>